AHF Urges President Biden to Support WTO IP Waiver
AIDS Healthcare Foundation (AHF) calls on President Biden to support a proposal for an expanded waiver on intellectual property (IP) rights for COVID-19 treatments and diagnostics currently being advanced at the World Trade Organization (WTO) despite opposition in the U.S. Congress.
"Opposition to the WTO IP waiver by some members of Congress is shortsighted and misplaced. Technological protectionism and vaccine hoarding during the pandemic cost the world millions of lives and trillions of dollars, while Big Pharma made off with record-breaking profits," said AHF President Michael Weinstein. "We urge President Biden to do the right thing in the name of global health security and public health and support the waiver. COVID-19 is clearly not over, and other pandemics are inevitable ? we must put people's lives first and be better prepared for the next global health disaster."
About AIDS Healthcare Foundation (AHF)
AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare
Results from the DESTINY-Breast12 phase 3b/4 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated substantial overall and intracranial clinical activity in a large cohort of patients with HER2 positive metastatic breast cancer who have...
Results from the DESTINY-Breast12 Phase IIIb/IV trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated substantial overall and intracranial clinical activity in a large cohort of patients with HER2-positive metastatic breast cancer...
Sylvan Learning of Johnston & Des Moines is proud to announce that it has been awarded a $450,000 grant funded by the State of Iowa to provide accelerated after-school tutoring to students in Des Moines Public Schools. The grant, part of Iowa's...
Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to...
For most students attending college, a reliable internet connection is something they can count on. For students attending Claflin University, a small Historically Black College and University (HBCU) located in rural Orangeburg, South Carolina,...
Amgen today announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking place Sept. 13-17 in Barcelona. The abstracts showcase data from...